cabergoline has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, M; Ishibashi, R; Kurosaki, Y; Maki, Y; Uchino, K; Yamagata, S | 1 |
1 other study(ies) available for cabergoline and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Pituitary Apoplexy in Long-Term Cabergoline User During Thrombocytopenia Due to Chemotherapy for Chronic Myelocytic Leukemia.
Topics: Cabergoline; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Long-Term Care; Magnetic Resonance Imaging; Middle Aged; Neuroendoscopy; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Thrombocytopenia; Tomography, X-Ray Computed | 2018 |